Christoph Bode
About
Christoph Bode is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Christoph Bode has authored 419 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Cardiology and Cardiovascular Medicine, 122 papers in Surgery and 62 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christoph Bode's work include Acute Myocardial Infarction Research (102 papers), Antiplatelet Therapy and Cardiovascular Diseases (87 papers) and Atrial Fibrillation Management and Outcomes (75 papers). Christoph Bode is often cited by papers focused on Acute Myocardial Infarction Research (102 papers), Antiplatelet Therapy and Cardiovascular Diseases (87 papers) and Atrial Fibrillation Management and Outcomes (75 papers). Christoph Bode collaborates with scholars based in Germany, United States and Netherlands. Christoph Bode's co-authors include Daniel Duerschmied, Marc Cohen, Karlheinz Peter, Keith A.A. Fox, Freek W.A. Verheugt, C. Michael Gibson, Paul Burton, Dawid L. Staudacher, Ingo Ahrens and Nadine Herr and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.
In The Last Decade
Christoph Bode
404 papers receiving 12.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Christoph Bode Germany | 50 | 7.3k | 3.8k | 2.3k | 1.6k | 1.4k | 419 | 12.7k | ||
| Joseph C. Cleveland United States | 48 | 15.7k 2.1× | 3.6k 1.0× | 2.6k 1.1× | 1.2k 0.8× | 1.3k 0.9× | 207 | 20.1k | ||
| Frank W. Sellke United States | 65 | 7.1k 1.0× | 5.9k 1.6× | 1.1k 0.5× | 2.2k 1.4× | 5.8k 4.0× | 575 | 22.7k | ||
| Charles R. Bridges United States | 38 | 6.1k 0.8× | 3.5k 0.9× | 757 0.3× | 849 0.5× | 1.1k 0.8× | 114 | 9.8k | ||
| Emile R. Mohler United States | 58 | 6.7k 0.9× | 5.5k 1.5× | 988 0.4× | 4.1k 2.6× | 2.3k 1.6× | 237 | 16.1k | ||
| James H. Chesebro United States | 57 | 10.4k 1.4× | 6.9k 1.8× | 2.3k 1.0× | 2.5k 1.6× | 1.3k 0.9× | 175 | 16.4k | ||
| Alan D. Michelson United States | 64 | 7.4k 1.0× | 3.5k 0.9× | 3.2k 1.4× | 1.7k 1.1× | 1.3k 0.9× | 237 | 15.0k | ||
| Andrew D. Blann United Kingdom | 71 | 5.8k 0.8× | 2.2k 0.6× | 2.5k 1.1× | 1.9k 1.2× | 3.5k 2.4× | 338 | 15.5k | ||
| Hugo Van Aken Germany | 61 | 4.4k 0.6× | 6.7k 1.8× | 563 0.2× | 2.3k 1.5× | 1.1k 0.8× | 580 | 16.2k | ||
| Juan J. Badimón United States | 70 | 8.7k 1.2× | 8.3k 2.2× | 1.8k 0.8× | 4.6k 2.9× | 3.4k 2.4× | 305 | 21.3k | ||
| C. R. Valeri United States | 62 | 2.8k 0.4× | 3.3k 0.9× | 955 0.4× | 2.2k 1.4× | 1.4k 1.0× | 387 | 15.1k |
Countries citing papers authored by Christoph Bode
Since
Specialization
Citations
This map shows the geographic impact of Christoph Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Bode more than expected).
Fields of papers citing papers by Christoph Bode
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Christoph Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Bode. The network helps show where Christoph Bode may publish in the future.
Co-authorship network of co-authors of Christoph Bode
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Bode. A scholar is included among the top collaborators of Christoph Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Bode. Christoph Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Luxenburger, Hendrik, Maike Hofmann, Christoph Neumann‐Haefelin, et al.. (2023). Decreased level of serum NT-proCNP associates with disease severity in COVID-19. Respiratory Research. 24(1). 174–174.
2.
Rieder, Marina, Daniela Stallmann, Maike Hofmann, et al.. (2023). Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function. Research and Practice in Thrombosis and Haemostasis. 7(1). 100025–100025.
3.
Marquis‐Gravel, Guillaume, Zhen Huang, Steven L. Zelenkofske, et al.. (2022). Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention. Journal of the American Heart Association. 12(1). e025666–e025666.
4.
Härdtner, Carmen, Maximilian Mauler, Bianca Dufner, et al.. (2022). Elevated platelet–leukocyte complexes are associated with, but dispensable for myocardial ischemia–reperfusion injury. Basic Research in Cardiology. 117(1). 61–61.
5.
Bode, Christoph, et al.. (2021). Shear Wave Elastography as a Novel Ultrasound Method for Monitoring Exercise Capacity of Patients with Congestive Heart Failure. 3(1).
6.
Reichardt, Wilfried, Beat A. Kaufmann, Dominik von Elverfeldt, et al.. (2021). P2Y12 Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction. Cells. 10(12). 3414–3414.
7.
Stachon, Peter, Klaus Kaier, Philip Hehn, et al.. (2021). Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany. Clinical Research in Cardiology. 111(7). 742–749.
8.
Kessler, Thorsten, Tobias Graf, Ingo Hilgendorf, et al.. (2020). Hospital admissions with acute coronary syndromes during the COVID-19 pandemic in German cardiac care units. Cardiovascular Research. 116(11). 1800–1801.
9.
Rieder, Marina, Thilo Witsch, Nancy Schanze, et al.. (2020). Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury. Applied Sciences. 10(18). 6379–6379.
10.
Olivier, Christoph B., Susanne Weber, Philipp Diehl, et al.. (2016). Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors. Journal of Thrombosis and Thrombolysis. 42(2). 161–166.
11.
Rilinger, Jonathan, Jennifer S. Esser, Qian Zhou, et al.. (2016). High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting. Journal of Thrombosis and Thrombolysis. 42(4). 558–565.
12.
Heidt, Timo, Jan‐Bernd Hövener, Irene Neudorfer, et al.. (2016). Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging. Scientific Reports. 6(1). 25044–25044.
13.
Gibson, C. Michael, Duane S. Pinto, Gerald Chi, et al.. (2016). Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation. 135(4). 323–333.
14.
Odening, Katja E., Jeanne M. Nerbonne, Christoph Bode, Manfred Zehender, & Michael Brunner. (2009). In Vivo Effect of a Dominant Negative Kv4.2 Loss-of-Function Mutation Eliminating I_ on Atrial Refractoriness and Atrial Fibrillation in Mice(Arrhythmia/Electrophysiology). Japanese Circulation Journal-english Edition. 73(3). 461–467.
15.
Bode, Christoph & Freek W.A. Verheugt. (2009). The need for new oral anticoagulants in clinical practice: an introduction. Journal of Cardiovascular Medicine. 10(8). 593–594.
16.
Ahrens, Ingo, Meike Schwarz, Karlheinz Peter, & Christoph Bode. (2007). Therapeutic Inhibitors of Platelet Aggregation – from Aspirin to Integrin Blockersf. Transfusion Medicine and Hemotherapy. 34(1). 44–54.
17.
Ahrens, Ingo, et al.. (2007). Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology. Expert Opinion on Drug Metabolism & Toxicology. 3(4). 609–620.
18.
Hoefer, Imo E., Sebastian Grundmann, Stephan H. Schirmer, et al.. (2005). Aspirin, But Not Clopidogrel, Reduces Collateral Conductance in a Rabbit Model of Femoral Artery Occlusion. Journal of the American College of Cardiology. 46(6). 994–1001.
19.
Chang, Wei‐Chiao, Prashant Kaul, Amadeo Betriu, et al.. (2003). What is an Optimal Rate of Early Revascularization After ST-elevation Myocardial Infarction? Insights from the GUSTO-V Trial. Circulation. 108(17).
20.
O’Shea, J.Conor, Robert G. Wilcox, Allan M. Skene, et al.. (2002). Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone. The American Journal of Cardiology. 90(12). 1374–1377.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Joseph C. Cleveland Breakdown of academic impact, for papers by Frank W. Sellke Breakdown of academic impact, for papers by Charles R. Bridges Breakdown of academic impact, for papers by Emile R. Mohler Breakdown of academic impact, for papers by James H. Chesebro Breakdown of academic impact, for papers by Alan D. Michelson Breakdown of academic impact, for papers by Andrew D. Blann Breakdown of academic impact, for papers by Hugo Van Aken Breakdown of academic impact, for papers by Juan J. Badimón Breakdown of academic impact, for papers by C. R. Valeri